Zebrafish Xenotransplantation

The larvae’s immature adaptive immune system helps support the presence of introduced tumor cells during observation. This feature allows researchers to examine tumor behavior in a living vertebrate without focusing on rapid adaptive immune rejection as the primary experimental outcome. Consequently, investigators can monitor growth, migration, invasion, and treatment responses over a practical experimental period.

Fluorescently labeled tumor cells can be visualized through the optically transparent zebrafish embryo or larva. This combination enables real-time imaging rather than relying only on endpoint measurements, allowing investigators to follow where cells move, how tumors develop, and whether cells interact with blood vessels. Accessible transplantation sites further support direct observation within the living animal.

The model can reveal several dynamic features of cancer biology, including tumor growth, cell migration, invasion, and interactions with blood vessels. Observing these processes in vivo helps researchers assess metastatic behavior rather than measuring tumor cells only in isolation. The same system also supports examination of how different treatments influence these behaviors during an experiment.

Researchers introduce tumor cells from humans or other organisms into zebrafish embryos or larvae, commonly after labeling the cells with fluorescent markers. The cells are placed into accessible sites, where their behavior can be monitored by imaging. Investigators then examine growth, migration, invasion, vascular interactions, or responses to candidate anticancer treatments in the living larvae.

Its small size and scalability allow researchers to evaluate anticancer drug responses across multiple zebrafish larvae in a relatively rapid experimental format. Investigators can compare treatments while observing effects on tumor behavior in vivo, including growth and metastatic features. This makes the approach useful for early-stage therapeutic screening before more extensive studies are pursued.

Tumor cells obtained from individual patients can be introduced into zebrafish larvae, creating an in vivo setting for comparing treatment responses. Researchers can then examine how candidate therapies affect the transplanted cells and use those observations to distinguish potentially informative treatment options. The approach therefore connects patient-derived tumor behavior with rapid, comparative drug-response testing.

After transplantation, investigators can compare tumor growth, cell migration, invasion, blood-vessel interactions, and responses to different anticancer treatments. Fluorescent imaging makes these outcomes observable in living larvae, while the model’s speed and scalability support analysis across multiple conditions. Such comparisons help researchers investigate cancer mechanisms and identify treatments for further evaluation.